February 5, 2026

Fatty acids found to influence immune defense during chronic infections

February 5, 2026 / Research update / InnovateMed Author / fatty acids

by Mario Aguilera, University of California – San Diego edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Unsplash/CC0 Public Domain Our immune system employs an array of strategies to combat infectious threats. White blood cells called cytotoxic T lymphocytes, or “CD8 T cells,” are soldiers of the immune system, […]

Fatty acids found to influence immune defense during chronic infections Read More »

Five mutational ‘fingerprints’ could help predict how visible tumors are to the immune system

February 5, 2026 / Research update / InnovateMed Author / tumors

by HUN-REN Szegedi Biológiai Kutatóközpont edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility, supporting the idea that immunotherapy response depends on mutation ‘fingerprints’ and their protein-level consequences, not mutation counts alone.” Credit: Máté Manczinger, HUN-REN Szeged Biological

Five mutational ‘fingerprints’ could help predict how visible tumors are to the immune system Read More »

Experimental pill dramatically reduces ‘bad’ cholesterol

February 5, 2026 / Research update / InnovateMed Author / Bad cholesterol

by UT Southwestern Medical Center edited by Lisa Lock, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: JESHOOTS.com from Pexels An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as “bad” cholesterol, by up to 60%, according to a new phase three clinical trial published in the New England Journal of Medicine.

Experimental pill dramatically reduces ‘bad’ cholesterol Read More »

Blocking PTP1B protein may slow memory loss in Alzheimer’s

February 5, 2026 / Research update / InnovateMed Author / alzheimer

by Gina DiPietro, Cold Spring Harbor Laboratory edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source The Tonks lab studied PTP1B inhibition in a mouse model of Alzheimer’s disease. When PTP1B was deleted, as shown in the bottom row, the brain’s immune cells (green) were better at engulfing harmful amyloid-β plaques

Blocking PTP1B protein may slow memory loss in Alzheimer’s Read More »

Turning around the Titanic’: How the incoming PBM reforms will transform CMS

February 5, 2026 / Clinical Practice / InnovateMed Author / titanic

February 3, 2026 02:34 PM ESTUpdated 04:31 PM PharmaLaw ‘Turning around the Titanic’: How the incoming PBM reforms will transform CMS Zachary Brennan Senior Editor The Centers for Medicare and Medicaid Services has never played a significant role in regulating pharmacy benefit managers, the middlemen that have historically relied on high drug prices for profits.

Turning around the Titanic’: How the incoming PBM reforms will transform CMS Read More »

Best drinks for kidney clean

February 5, 2026 / Patient education / InnovateMed Author / kidney

Written by Cherilyn Davis, MD | Reviewed by Karen Hovav, MD, FAAP Updated on February 4, 2025 Di_Media/iStock via Getty Images Plus Looking for a Kidney Cleanse? Here Are the Best Drinks for Your Kidneys Staying hydrated by drinking water is one of the best ways to keep your kidneys healthy. Some research suggests that drinks like cranberry juice,

Best drinks for kidney clean Read More »

What if multiple sclerosis isn’t just one disease?

February 5, 2026 / Research update / InnovateMed Author / multiple sclerosis

By Chelsea Haney February 04, 2026 Facebook Twitter LinkedIn Reddit Flipboard Email The findings indicate MS could have two distinct degenerative pathways, one fast and the other slow. And this knowledge could help better inform patients and doctors. Depositphotos View 1 Images For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than

What if multiple sclerosis isn’t just one disease? Read More »

New stem cell treatment may offer hope for Parkinson’s disease

February 5, 2026 / Research update / InnovateMed Author / parkinson

Keck Medicine of USC investigates a unique therapy that aims to repair damaged brain cells Reports and ProceedingsUniversity of Southern California – Health Sciences image: Brian Lee, MD, PhD, is a neurosurgeon with Keck Medicine of USC and principal investigator of the study. view more Credit: Ricardo Carrasco III LOS ANGELES — Parkinson’s disease is a progressive neurodegenerative disorder that affects more

New stem cell treatment may offer hope for Parkinson’s disease Read More »

New approach to HIV treatment offers hope to reduce daily drug needs

February 5, 2026 / Research update / InnovateMed Author / HIV TREATMENT

Enhanced immune cells show promise in targeting viral reservoirs that current medications can’t eliminate Peer-Reviewed PublicationCase Western Reserve University image: Jonathan Karn view more Credit: Case Western Reserve University CLEVELAND— More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme

New approach to HIV treatment offers hope to reduce daily drug needs Read More »

Rates of autism in girls and boys may be more equal than previously thought

February 5, 2026 / Research update / InnovateMed Author / autism

by British Medical Journal edited by Sadie Harley, reviewed by Robert Egan Editors’ notes The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain Autism has long been viewed as a condition that predominantly affects male individuals, but a study from Sweden published by The BMJ shows that autism may actually occur at comparable rates among male and female individuals.

Rates of autism in girls and boys may be more equal than previously thought Read More »